Get started
Author

Ava P. Gustafson

Observed name: Ava Gustafson
ORCID: 0009-0000-3138-9264
Observed ORCID: 0009-0000-3138-9264
OpenAlex ID: A5115611694
Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients
2024 · Ali T. Arafa, Megan Ludwig, et al. · Cancers · 6
PDF
CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer
2025 · Allison Makovec, Ella Boytim, et al. · npj Precision Oncology · 4
PDF
Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancer
2025 · Aiden Deacon, Ava Gustafson, et al. · Oncotarget · 2
PDF
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer
2026 · Allison Makovec, Ava P. Gustafson, et al. · Clinical Cancer Research · 1
Data from B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer
2026 · Allison Makovec, Ava P. Gustafson, et al.
Supplemental Tables 2-10 from B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer
2026 · Allison Makovec, Ava P. Gustafson, et al.
Supplemental Table 1 from B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer
2026 · Allison Makovec, Ava P. Gustafson, et al.
Discrete Transcriptional States Define Biphasic Immune Response and Dynamic CMS Transitions in Colorectal Cancer
2026 · Khalid Ishani, Dechen Wangmo, et al. · bioRxiv (Cold Spring Harbor Laboratory)
CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer
2026 · Allison Makovec, John T. Phoenix, et al. · Oncotarget
PDF
Author Correction: CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer
2025 · Allison Makovec, Ella Boytim, et al. · npj Precision Oncology
PDF
Evaluating RSPO2 activation and its association with outcomes and potential role as a driver in double-negative prostate cancer (DNPC).
2025 · Aiden Deacon, Ava Gustafson, et al. · Journal of Clinical Oncology
Works count: 11
Citation count: 13
H-index: 2
I10-index:
Year
Topic
Type